Study: Methods used to manage post-TAVR patients are safe

01/22/2013 | Healio

Warfarin plus a single antiplatelet drug or, if bleeding is an issue, warfarin alone were safe for patients following transcatheter aortic valve replacement, according to a study in the American Journal of Cardiology. "In general, we believe that patients who have indications for long-term anticoagulation should continue with this therapy irrespective of the TAVR procedure," the study's authors wrote.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX